{"id":"https://openalex.org/W2171580322","doi":"https://doi.org/10.1200/jco.2012.47.5095","title":"Lymphocytic Vasculitis of the Uterus in a Patient With Melanoma Receiving Ipilimumab","display_name":"Lymphocytic Vasculitis of the Uterus in a Patient With Melanoma Receiving Ipilimumab","alternate_titles":[],"publication_year":2013,"publication_date":"2013-06-04","ids":{"openalex":"https://openalex.org/W2171580322","doi":"https://doi.org/10.1200/jco.2012.47.5095","mag":"2171580322","pmid":"https://pubmed.ncbi.nlm.nih.gov/23733772"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.47.5095","doi":"https://doi.org/10.1200/jco.2012.47.5095","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.47.5095","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2171580322"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033513252","display_name":"David R. Minor","orcid":"https://orcid.org/0000-0003-2186-2016","observed_orcids":["https://orcid.org/0000-0003-2186-2016"]},"institutions":[{"id":"https://openalex.org/I2801780550","display_name":"California Pacific Medical Center","ror":"https://ror.org/02bjh0167","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114073160","https://openalex.org/I2801780550"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David R. Minor","raw_affiliation_strings":["Center for Melanoma Research and Treatment; California Pacific Medical Center, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Melanoma Research and Treatment; California Pacific Medical Center, San Francisco, CA","institution_ids":["https://openalex.org/I2801780550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110844048","display_name":"Stephen R. Bunker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801780550","display_name":"California Pacific Medical Center","ror":"https://ror.org/02bjh0167","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114073160","https://openalex.org/I2801780550"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen R. Bunker","raw_affiliation_strings":["Center for Melanoma Research and Treatment; California Pacific Medical Center, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Melanoma Research and Treatment; California Pacific Medical Center, San Francisco, CA","institution_ids":["https://openalex.org/I2801780550"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113537106","display_name":"Judith Doyle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801780550","display_name":"California Pacific Medical Center","ror":"https://ror.org/02bjh0167","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114073160","https://openalex.org/I2801780550"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Judith Doyle","raw_affiliation_strings":["Center for Melanoma Research and Treatment; California Pacific Medical Center, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Melanoma Research and Treatment; California Pacific Medical Center, San Francisco, CA","institution_ids":["https://openalex.org/I2801780550"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2801780550"],"apc_list":null,"apc_paid":null,"fwci":1.0385,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.74434298,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"31","issue":"20","first_page":"e356","last_page":"e356"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lymphocytic-vasculitis","display_name":"lymphocytic vasculitis","score":0.9589999914169312},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8629999756813049},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.7509999871253967},{"id":"https://openalex.org/keywords/anti-thyroglobulin-antibodies","display_name":"thyroglobulin antibodies","score":0.8420000076293945},{"id":"https://openalex.org/keywords/hypophysitis","display_name":"hypophysitis","score":0.8169999718666077},{"id":"https://openalex.org/keywords/in-transit-metastases","display_name":"in-transit metastasis","score":0.6129999756813049},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.7929999828338623},{"id":"https://openalex.org/keywords/hysterectomy","display_name":"hysterectomy","score":0.6359999775886536},{"id":"https://openalex.org/keywords/antiphospholipid-syndrome","display_name":"antiphospholipid syndrome","score":0.6940000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9544084072113037},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.9275847673416138},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6190078258514404},{"id":"https://openalex.org/C2779066055","wikidata":"https://www.wikidata.org/wiki/Q9612","display_name":"Uterus","level":2,"score":0.5674926042556763},{"id":"https://openalex.org/C2776015282","wikidata":"https://www.wikidata.org/wiki/Q644318","display_name":"Vasculitis","level":3,"score":0.5524557828903198},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5020065307617188},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41239750385284424},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.394777774810791},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3205556273460388},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3015916347503662},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.25182628631591797},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.18218213319778442},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.11453515291213989}],"mesh":[{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001707","descriptor_name":"Biopsy, Needle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008198","descriptor_name":"Lymph Nodes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008206","descriptor_name":"Lymphatic Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008206","descriptor_name":"Lymphatic Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008207","descriptor_name":"Lymphatic Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008214","descriptor_name":"Lymphocytes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D009361","descriptor_name":"Neoplasm Invasiveness","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014599","descriptor_name":"Uterus","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D014599","descriptor_name":"Uterus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D014657","descriptor_name":"Vasculitis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D014657","descriptor_name":"Vasculitis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2012.47.5095","doi":"https://doi.org/10.1200/jco.2012.47.5095","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.47.5095","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:23733772","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23733772","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W1982086114","https://openalex.org/W2109653150"],"related_works":["https://openalex.org/W2396772706","https://openalex.org/W2600575708","https://openalex.org/W2061052668","https://openalex.org/W2985521507","https://openalex.org/W1999935292","https://openalex.org/W2113287405","https://openalex.org/W3116242027","https://openalex.org/W2624432149","https://openalex.org/W1767743048"],"abstract_inverted_index":{"Case":[0],"Report":[1],"A":[2,74],"77-year-old":[3],"woman":[4],"developed":[5,25],"in-transit":[6],"and":[7,32,67,128,138],"lymphatic":[8],"metastases":[9],"from":[10],"melanoma":[11],"after":[12,21],"multiple":[13],"previous":[14,106],"therapies.":[15],"She":[16,57,99],"received":[17,58],"four":[18],"dosesof":[19],"ipilimumab3mg/kgbeginninginSeptember2011.Fifteenweeks":[20],"starting":[22],"treatment,":[23],"she":[24,115],"hypophysitis":[26],"with":[27,93,133],"low":[28],"levels":[29],"of":[30,54,61,110,112,136,157],"cortisol":[31],"thyroid-stimulating":[33],"hormone;":[34],"her":[35,55],"symptoms":[36],"responded":[37],"to":[38,83],"appropriate":[39],"hormonal":[40],"replacement.":[41],"Positron":[42],"emission":[43],"tomography":[44,46,77],"(PET)/computed":[45],"scan":[47,78],"in":[48,65,79,88,119],"May":[49],"2012":[50,69,81],"documented":[51],"complete":[52],"remission":[53],"melanoma.":[56],"additional":[59],"doses":[60],"ipilimumab":[62],"3":[63],"mg/kg":[64],"March":[66],"June":[68],"without":[70],"apparent":[71],"adverse":[72],"effects.":[73],"routine":[75],"PET/computed":[76],"August":[80],"appeared":[82],"show":[84],"a":[85,117,154],"4.8-cm":[86],"mass":[87],"the":[89],"uterus":[90],"(SUV":[91],"9.2)":[92],"bilateral":[94],"iliac":[95,143],"lymphadenopathy":[96],"(Fig":[97,131],"1).":[98],"had":[100,116],"no":[101],"pelvic":[102],"pain,":[103],"bleeding,":[104],"or":[105],"gynecological":[107],"disease.":[108],"Because":[109],"suspicion":[111],"recurrent":[113],"malignancy":[114],"hysterectomy":[118],"September":[120],"2012.":[121],"Pathology":[122],"showed":[123,149],"lymphocytic":[124],"vasculitis":[125],"involving":[126],"uterine":[127],"ovarian":[129],"vessels":[130],"2),":[132],"transmural":[134],"infiltration":[135],"lymphocytes":[137],"focal":[139],"fibrin":[140],"deposition.":[141],"The":[142],"lymph":[144],"nodes":[145],"thatwereremovedshowedonlyreactivechanges.Serologic":[146],"studies":[147],"subsequently":[148],"normal":[150],"antinuclear":[151],"antibodies":[152],"but":[153],"high":[155],"titer":[156],"antithyroglobulin":[158],"antibody\u20143,591":[159],"IU/mL":[160],"(normal,":[161],"0-40":[162],"IU/mL).":[163]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2171580322","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
